Four-year results of a prospective single-arm study on 200 semi-constrained total cervical disc prostheses: clinical and radiographic outcome
- 1 November 2016
- journal article
- clinical trial
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 25 (5) , 556-565
Abstract
OBJECTIVE: Recent studies have described encouraging outcomes after cervical total disc replacement (cTDR), but there are also critical debates regarding the long-term effects of heterotopic ossification (HO) and the prevalence of adjacent-level degeneration. The aim in this paper was to provide 4-year clinical and radiographic outcome results on the activ C disc prosthesis. METHODS: A total of 200 subjects underwent single-level activ C (Aesculap AG) implantation between C-3 and C-7 for the treatment of symptomatic degenerative disc disease. Clinical and radiographic assessments were performed preoperatively, intraoperatively, at discharge, and again at 6 weeks, 6 months, 1 year, 2 years, and 4 years. Radiographic evaluations were done by an independent core laboratory using a specific software for quantitative motion analysis. RESULTS: Neck Disability Index (NDI) and visual analog scale (VAS) score for neck and arm pain decreased significantly from baseline to the 4-year follow-up. The mean improvement for NDI was 20, for VAS severity and frequency of neck pain 26.4 and 28, and for VAS severity and frequency of arm pain 30.7 and 35.1, respectively. The neurological situation improved for the majority of patients (86.4%); 76.1% of cases were asymptomatic. Subsequent surgical interventions were reported in 7% of the cases, including device removals in 3%. In 2.5% a subsidence greater than 3 mm was recorded; 1 of these cases also had a migration greater than 3 mm. No device displacement, expulsion, disassembly, loose or fractured device, osteolysis, or facet joint degeneration at the index level was observed. Segmental lordotic alignment changed from −2.4° preoperatively to −6.2° at 4 years, and postoperative height was maintained during the follow-up. Advanced HO (Grade III and IV) was present in 27.1% of the cases; 82.4% showed segmental mobility. A progression of radiographic adjacent-segment degeneration occurred in 28.2%, but only 4.5% required surgical treatment. CONCLUSIONS: The activ C is a safe and effective device for cervical disc replacement confirming the encouraging results after cTDR. Clinical trial registration no.: NCT02492724 (clinicaltrials.gov)Keywords
This publication has 56 references indexed in Scilit:
- Detecting relevant changes and responsiveness of Neck Pain and Disability Scale and Neck Disability IndexEuropean Spine Journal, 2012
- The Incidence of Adjacent Segment Degeneration after Cervical Disc Arthroplasty (CDA): A Meta Analysis of Randomized Controlled TrialsPLOS ONE, 2012
- Prevalence of heterotopic ossification after cervical total disc arthroplasty: a meta-analysisEuropean Spine Journal, 2011
- Superiority of the Bryan® Disc Prosthesis for Cervical Myelopathy: A Randomized Study with 3-year FollowupClinical Orthopaedics and Related Research, 2011
- Prospective Analysis of Imaging Prediction of Pseudarthrosis After Anterior Cervical Discectomy and FusionSpine, 2011
- Artificial total disc replacement versus fusion for the cervical spine: a systematic reviewEuropean Spine Journal, 2010
- Clinical results and development of heterotopic ossification in total cervical disc replacement during a 4-year follow-upEuropean Spine Journal, 2009
- Intermediate clinical and radiological results of cervical TDR (Mobi-C®) with up to 2 years of follow-upEuropean Spine Journal, 2009
- Observer agreement in assessing flexion-extension X-rays of the cervical spine, with and without the use of quantitative measurements of intervertebral motionThe Spine Journal, 2007
- Kyphotic malalignment after anterior cervical fusion is one of the factors promoting the degenerative process in adjacent intervertebral levelsEuropean Spine Journal, 2001